Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Transdermal drug delivery firm Zosano Pharma nets $46mm in IPO

Executive Summary

Seven months after filing, transdermal drug delivery firm Zosano Pharma Corp. netted $46mm in its initial public offering of 4.5mm shares at $11. In July Zosano had announced plans to offer 6.4mm shares priced between $10-12 and revised it to 3mm shares earlier this month.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Macromolecule
      • Transdermal
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies